For people with lung or pancreatic cancer driven by changes in the KRAS gene, research presented at the 2026 European Society ...
Researchers are exploring new options for patients with relapsed or refractory hairy cell leukemia, including chimeric ...
For patients with hairy cell leukemia whose cancer returns after multiple treatments, researchers are investigating whether ...
Adding Imdelltra (tarlatamab) to Imfinzi (durvalumab) maintenance therapy helped people with extensive-stage small cell lung ...
The FDA previously approved FoundationOne CDx, which uses a tumor tissue sample, and FoundationOne Liquid CDx, which uses a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results